This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ohtsuka, K Articles by Horwitz, D A Search for Related Content PubMed PubMed Citation Articles by Ohtsuka, K Articles by Horwitz, D A Social Bookmarking                         What's this?

The relationship between defects in lymphocyte production of transforming growth factor-ß1 in systemic lupus erythematosus and disease activity or severity

J D Gray

M M Stimmler

University of Southern California School of Medicine, Los Angeles, CA 90033 USA

D A Horwitz

University of Southern California School of Medicine, Los Angeles, CA 90033 USA; University of Southern California School of Medicine, Division of Rheumatology and Immunology, 2011 Zonal Ave. HMR-711, Los Angeles, CA 90033, USA

Transforming growth factor ß (TGF-ß) comprises of a family of proteins with pleiotropic signaling properties and potent immunoregulatory effects. In SLE we recently reported that lymphocyte production of the total and active forms of TGFß₁ was decreased. Here we asked whether these defects correlate with disease activity and/or severity. TGF-ß₁ production by blood lymphocytes from 17 prospectively studied SLE patients was compared with 10 rheumatoid arthritis (RA) patients and 23 matched healthy controls. The RA levels of active TGF-ß₁ were lower than controls, but were not deceased to the extent found in SLE. Levels of constitutive and anti-CD2 stimulated active TGF-ß₁ detected in picomolar amounts were markedly reduced in six untreated patients hospitalized with recent onset, very active and severe SLE and similarly reduced in 11 patients with treated, less active disease. By contrast, decreased production of total TGF-ß₁inversely correlated with disease activity. These studies suggest, therefore, that although impaired lymphocyte secretion of the latent precursor of TGF-ß₁ may result as a consequence of disease activity, a decreased capacity to convert the precursor molecule to its active form may pre-date disease onset. Insufficient exposure of T cells to picomolar concentrations of TGF-ß₁ at the time they are activated can result in impaired down-regulation of 1g synthesis. Therefore, decreased lymphocyte production of active TGF-ß₁ in SLE could be an immunologic defect which contributes to the B cell hyperactivity characteristic of this disease.

Key Words: cytokines • systemic lupus erythematosus • transforming growth factor-beta

Lupus, Vol. 8, No. 2, 90-94 (1999)
DOI: 10.1191/096120399678847489


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A M Hammad, H M Youssef, and M M El-Arman Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis Lupus, September 1, 2006; 15(9): 608 - 612. [Abstract] [PDF]

				H. S. Howe, P. L. Cheung, K. O. Kong, H. Badsha, B. Y. H. Thong, K. P. Leong, E. T. Koh, T. Y. Lian, Y. K. Cheng, S. Lam, et al. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis Rheumatology, January 1, 2005; 44(1): 51 - 54. [Abstract] [Full Text] [PDF]

				H Schotte, P Willeke, S Rust, G Assmann, W Domschke, M Gaubitz, and B Schluter The transforming growth factor-{beta}1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 86 - 92. [Abstract] [PDF]

				G. S Dean, J. Tyrrell-Price, E. Crawley, and D. A Isenberg Cytokines and systemic lupus erythematosus Ann Rheum Dis, April 1, 2000; 59(4): 243 - 251. [Full Text]

				P. Youinou and R. Le Corre The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus Lupus, February 1, 1999; 8(2): 87 - 88. [PDF]